AI predicts COPD flare-ups: 100,000 patients studied

NCT ID NCT05825014

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will analyze data from 100,000 COPD patients in Hong Kong to build computer models that predict who is likely to be readmitted to the hospital or die within a year. The goal is to help doctors identify high-risk patients early. No new treatments are being tested; instead, the researchers are looking for patterns in existing health records.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better tools for doctors to identify COPD patients at high risk of readmission or death, allowing earlier interventions.

What could go wrong

This is an observational study using historical data, so it cannot prove that any intervention works. The models may not apply to other populations or healthcare systems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD EXACERBATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Chinese University of Hong Kong

    RECRUITING

    Hong Kong, New Territories, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••